Cohesive Gel Implant Study
**This breast implant clinical trial recently completed. Please check back for information future trials**
Turkle & Associates is pleased to announce that Dr. Janet K. Turkle is one of a limited number of surgeons in the United States now enrolling patients interested in the Inamed 410 Cohesive Gel Breast Implants.
The FDA has approved enrollment of additional patients in the study over the next six months. The trials are open to patients seeking a first time augmentation, reconstruction and revision.
Eligibility for these implants, sometimes called “gummy bear” implants, can only be determined after an in-person consultation.
Although cohesive implants have been widely used in Europe since 1994, the FDA requires a large-scale study be conducted in the United States before giving these implants final approval.
Instead of being filled with saline or a liquid silicone gel, the 410 cohesive gel breast implants are filled with a cohesive silicone that is described as a “soft solid”. Therefore, one of the main advantages of the breast implants is that they seem to retain their shape.
Although this is a study, the usual breast augmentation charges apply. All costs, including the services of the surgeon and the cost of the implants, are the responsibility of the patients participating in the study.
Participation in the study will require patients to return for annual follow-up visits for ten years. Patients will be compensated for their time for each visit. Because of the requirement for annual visits, patients must live in the greater Indianapolis area.
Turkle & Associates provides a variety of saline implants for the patient not interested in considering a cohesive gel implant.
If you would like to learn more about our clinical study of Cohesive Gel breast Implants at our Indianapolis practice, please click here to contact Turkle & Associates today.